Search Results 1541-1550 of 16378 for dermatitis atópica

  1. Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma - Mayo Clinic

    No prior use of topical skin-lightening agents for 1 month prior to study entry; Good general health as confirmed by medical history; Female patients of child ...

  2. Real-time Disease Monitoring of Metastatic Breast Cancer to Optimize Treatment - Mayo Clinic

    Patients with a prior or concurrent malignancy, excluding non-melanoma skin cancers and non-invasive cancers whose natural history or treatment does not ...

  3. Study for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients - Mayo Clinic

    Have active malignancy with the exception of nonmelanoma skin cancer, as determined by the investigator. Subjects who experience relapse or progression of ...

  4. A Study to Determine the Effects of a Mechanical Device to Treat Swelling of the Face and Neck Following Treatment for Cancer. - Mayo Clinic

    Participation eligibility · Prior surgery, radiation, chemotherapy, or immunotherapy for head or neck cancer. · Acute radiation dermatitis, unhealed surgical ...

  5. Daratumumab in Primary Antiphospholipid Syndrome (DARE-APS) - Mayo Clinic

    Skin biopsy documentation of livedoid vasculopathy. History of triple positive aPL within the prior 5 years and at least 12 weeks prior to enrollment ...

  6. Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer - Mayo Clinic

    Exceptions include basal cell carcinoma of the skin or squamous cell carcinoma of the skin that has undergone potentially curative therapy or in situ cervical ...

  7. A Study of the Bacteria Found in Cancerous and Non-cancerous Breast Tissue - Mayo Clinic

    Prior history of breast cancer or any other invasive cancer other than non-melanoma skin cancer . Documented chlorhexidine gluconate allergy. Male patients ...

  8. Relapse Prediction Following Discontinuation of Tocilizumab In Giant Cell Arteritis - Mayo Clinic

    Current (other than non-melanoma skin cancer) malignancy or active infection. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...

  9. MBI Response toTam - Mayo Clinic

    quinidine (Quinidex) 6) Personal history of any type of malignancy, with the exclusion of non-melanoma skin cancer, diagnosed prior to enrollment 7 ...

  10. A Study to See if New Device Technology Can Tell the Difference Between Non-cancer and Cancerous Melanoma - Mayo Clinic

    The purpose of this study is to use new technology called Optical Transfer Diagnosis (OTD) to find if skin lesions are melanomas or non cancer. The research ...